Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 5/20 | 0.52 |
| ▸ | HTT | P42858 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | AURKA | O14965 | 2/20 | 0.38 |
| ▸ | DAPK3 | O43293 | 2/20 | 0.38 |
| ▸ | JAK2 | O60674 | 2/20 | 0.38 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.38 |
| ▸ | PAK4 | O96013 | 2/20 | 0.38 |
| ▸ | ABL1 | P00519 | 2/20 | 0.38 |
| ▸ | RET | P07949 | 2/20 | 0.38 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.38 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.38 |
| ▸ | FLT1 | P17948 | 2/20 | 0.38 |
| ▸ | LTK | P29376 | 2/20 | 0.38 |
| ▸ | GRK5 | P34947 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29470857 | 1.00 | DYRK1A (0.52) | DYRK1AHTTKMT2AALDH1A1MAPT | |
| SCHEMBL12565427 | 0.84 | HTT (0.44) | DYRK1AHTTKMT2AALDH1A1MAPT | |
| SCHEMBL30466588 | 0.83 | DYRK1A (0.41) | DYRK1AHTTKMT2AALDH1A1MAPT | |
| SCHEMBL29796470 | 0.81 | HTT (0.53) | DYRK1AHTTKMT2AALDH1A1MAPT | |
| SCHEMBL335171 | 0.81 | HTT (0.53) | DYRK1AHTTKMT2AALDH1A1MAPT | |
| SCHEMBL29967332 | 0.79 | DYRK1A (0.38) | DYRK1AHTTKMT2AALDH1A1MAPT | |
| SCHEMBL208674 | 0.79 | DYRK1A (0.38) | DYRK1AHTTKMT2AALDH1A1MAPT | |
| SCHEMBL17548779 | 0.78 | NPC1 (0.53) | DYRK1AALDH1A1MAPTSMN1; SMN2MAPK1 | |
| SCHEMBL30874963 | 0.77 | HTT (0.46) | DYRK1AHTTKMT2AALDH1A1MAPT | |
| SCHEMBL29171765 | 0.77 | HTT (0.46) | DYRK1AHTTKMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025123383-A1 | ORGANIC COMPOUND AND DISPLAY PANEL | 武汉华星光电半导体显示技术有限公司 | 2025-06-19 | — | — | WO | disclosed |
| US-20250197427-A1 | ORGANIC COMPOUNDS AND DISPLAY PANELS | WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2025-06-19 | — | — | US | disclosed |
| WO-2024258154-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 진웅산업 | 2024-12-19 | — | — | WO | disclosed |
| WO-2024258156-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 진웅산업 | 2024-12-19 | — | — | WO | disclosed |
| WO-2024258158-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 주식회사 진웅산업 | 2024-12-19 | — | — | WO | disclosed |
| CN-117720565-A | Organic compound and display panel | 武汉华星光电半导体显示技术有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-114213409-A | Material for organic electroluminescent element, and consumer product | 上海八亿时空先进材料有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-106554352-B | Polycyclic aromatic hydrocarbon derivative containing naphthyridine group and application thereof | 北京鼎材科技有限公司 | 2020-12-08 | — | — | CN | disclosed |
| US-10629819-B2 | Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same | DUK SAN NEOLUX CO., LTD (KR) | 2020-04-21 | — | — | US | disclosed |
| US-10381574-B2 | Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same | DUK SAN NEOLUX CO., LTD. (KR) | 2019-08-13 | — | — | US | disclosed |
| US-20050272736-A1 | Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands | ABBVIE INC. | 2005-12-08 | — | — | US | disclosed |
| US-20050272728-A1 | Bicyclic-substituted amines having cyclic-substituted monocyclic substituents | ABBVIE INC. | 2005-12-08 | — | — | US | disclosed |
| WO-2005113536-A2 | TRI- AND BI-CYCLIC HETEROARYL HISTAMINE-3 RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2005-12-01 | — | — | WO | disclosed |
| WO-2005113551-A1 | BICYCLIC-SUBSTITUTED AMINES HAVING CYCLIC-SUBSTITUTED MONOCYCLIC SUBSTITUENTS | ABBOTT LABORATORIES (US) | 2005-12-01 | — | — | WO | disclosed |
| US-20050256309-A1 | Tri-and bi-cyclic heteroaryl histamine-3 receptor ligands | ABBOTT LABORATORIES | 2005-11-17 | — | — | US | disclosed |
| US-20050256118-A1 | Bicyclic-substituted amines having cyclic-substituted monocyclic substituents | ABBOTT LABORATORIES | 2005-11-17 | — | — | US | disclosed |
| EP-1569637-A1 | BICYCLIC-SUBSTITUTED AMINES AS HISTAMINE-3 RECEPTOR LIGANDS | Abbott Laboratories (US) | 2005-09-07 | — | — | EP | disclosed |
| US-20040152704-A1 | Bicyclic-substituted amines as histamine-3 receptor ligands | ABBVIE INC. | 2004-08-05 | — | — | US | disclosed |
| WO-2004043458-A1 | BICYCLIC-SUBSTITUTED AMINES AS HISTAMINE-3 RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2004-05-27 | — | — | WO | disclosed |
| US-20040092521-A1 | Bicyclic-substituted amines as histamine-3 receptor ligands | ABBOTT LABORATORIES | 2004-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10629819-B2 | Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same | ORAI2, VDAC2, PIEZO1 | DYRK1A 4019/4885HTT 666/4885KMT2A 727/4885 |
| US-20050272736-A1 | Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands | HRH3, HRH4, HRH2 | DYRK1A 436/4885HTT 1732/4885KMT2A 785/4885 |
| US-20050272728-A1 | Bicyclic-substituted amines having cyclic-substituted monocyclic substituents | HRH3, HRH4, HRH2 | DYRK1A 577/4885HTT 2795/4885KMT2A 523/4885 |
| US-20050256118-A1 | Bicyclic-substituted amines having cyclic-substituted monocyclic substituents | HRH3, HRH4, HRH2 | DYRK1A 577/4885HTT 2795/4885KMT2A 523/4885 |
| US-10381574-B2 | Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same | ORAI2, VDAC2, PIEZO1 | DYRK1A 4019/4885HTT 666/4885KMT2A 727/4885 |
| US-20050256309-A1 | Tri-and bi-cyclic heteroaryl histamine-3 receptor ligands | HRH3, HRH4, HRH2 | DYRK1A 436/4885HTT 1732/4885KMT2A 785/4885 |
| US-20250197427-A1 | ORGANIC COMPOUNDS AND DISPLAY PANELS | CHRM1, CHRM2, C1S | DYRK1A 2720/4885HTT 4043/4885KMT2A 3867/4885 |
| US-20040092521-A1 | Bicyclic-substituted amines as histamine-3 receptor ligands | HRH3, HRH4, HRH1 | DYRK1A 4076/4885HTT 2298/4885KMT2A 1805/4885 |
| US-20040152704-A1 | Bicyclic-substituted amines as histamine-3 receptor ligands | HRH3, HRH4, HRH1 | DYRK1A 3693/4885HTT 2308/4885KMT2A 1877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.